Singapore markets closed
Straits Times Index
3,303.19 +10.26 (+0.31%) S&P 500
5,158.23 +30.44 (+0.59%) Dow
38,730.00 +54.32 (+0.14%) Nasdaq
16,276.32 +119.99 (+0.74%) Bitcoin USD
63,614.61 -782.70 (-1.22%) CMC Crypto 200
1,367.49 +54.87 (+4.18%)
Ovid Therapeutics Inc. (OVID)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 11:35AM EDT. Market open.
| Previous close | 3.0600 |
| Open | 3.0200 |
| Bid | 3.0000 x 100 |
| Ask | 3.0300 x 100 |
| Day's range | 3.0000 - 3.1377 |
| 52-week range | 2.5700 - 4.1390 |
| Volume | |
| Avg. volume | 214,486 |
| Market cap | 213.14M |
| Beta (5Y monthly) | 0.69 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Beam Therapeutics Inc. (BEAM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Beam Therapeutics (BEAM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Ovid Therapeutics (OVID) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Ovid Therapeutics (OVID) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
We Think Ovid Therapeutics (NASDAQ:OVID) Can Afford To Drive Business Growth
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
© 2024 Yahoo. All rights reserved.